Professor, Medicine, University of Washington School of Medicine
Hematology
Dr. Effie W. Petersdorf, MD
|
|
Give Review
Effie W. Petersdorf, MD practices Hematology. Effie Petersdorf is a published doctor. She published 55 publications, including: 'Indications and Results of Human Leukocyte Antigen-identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease.'
Publications
- Impact of Allele-Level HLA Mismatch on Outcomes in Recipients of Double Umbilical Cord Blood Transplantation.
- Indications and Results of Human Leukocyte Antigen-identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease.
- High HLA-DP Expression and Graft-versus-Host Disease.
- Donor activating KIR2DS1 in Leukemia.
- HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.
- Non-permissive -DPB1 mismatch among otherwise HLA-matched donor-recipient pairs results in increased oVerall mortality after myeloablative unrelated allogeneic hematop...
- Comparison of statistics in association tests of genetic markers for survival outcomes.
- Genetic variation in the TLR and NF-κB pathways and cervical and vulvar Cancer risk: A population-based case-control study.
- The major histocompatibility complex: a model for understanding Graft-versus-host disease.
- Identification of the MICA*070 allele by sequencing and phasing.
- Incidence, risk factors and outcomes of sclerosis in patients with Chronic graft-versus-host disease.
- Multiple mismatches at the low expression HLA loci DP, DQ, DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation.
- 16th IHIW: international histocompatibility working group in hematopoietic cell transplantation.
- Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation.
- Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar Cancer risk: A hybrid case-parent triad and case-control study.
- Genetics of Graft-versus-host disease: The major histocompatibility complex.
- MHC-Resident Variation Affects Risks After Unrelated Donor Hematopoietic Cell Transplantation.
- Genetic variation in CD83 and risks of cervical and vulvar Cancers: A population-based case-control study.
- Risk factors associated with increased non-relapse mortality and with poor overall survival in children with Chronic graft-versus-host disease.
- Classifying Cytogenetics in Patients with AML in Complete Remission Undergoing Allogeneic Transplantation: A CIBMTR Study.
- One-Antigen Mismatched Related versus HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation in Adults with Acute Leukemia: Center for International Blood...
- Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of Breast cancer.
- Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.
- Comparative analysis of risk factors for Acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus...
- Risk of cervical Cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine cluster.
- Tumor necrosis factor polymorphism affects transplantation outcome in patients with myelodysplastic syndrome but not in those with chronic myelogenous Leukemia, indepe...
- Outcomes of pediatric bone marrow transplantation for Leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors.
- What is the role for donor natural killer cells after nonmyeloablative conditioning?
- HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid Leukemia.
- The graft-versus-Leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.
- IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantation.
- New advances in hematopoietic cell transplantation.
- Cervical and vulvar Cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2.
- Genetics of allogeneic hematopoietic cell transplantation. Role of HLA matching, functional variation in immune response genes.
- The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation.
- MHC haplotype matching for unrelated hematopoietic cell transplantation.
- An Acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens.
- Long-range multilocus haplotype phasing of the MHC.
- Genetics of risk factors for Graft-versus-host disease.
- Genomic polymorphism and allogeneic hematopoietic transplantation outcome.
- Nomenclature for Factors of the HLA System, 2004.
- Human leukocyte antigen matching in unrelated donor hematopoietic cell transplantation.
- Duration of immunosuppressive treatment for Chronic graft-versus-host disease.
- HLA matching in allogeneic stem cell transplantation.
- Limits of HLA mismatching in unrelated hematopoietic cell transplantation.
- Evaluation of a CD25-specific immunotoxin for prevention of Graft-versus-host disease after unrelated marrow transplantation.
- Increasingly frequent diagnosis of Acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.
- Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
- Nomenclature for factors of the HLA system, 2002.
- Structural studies of allelic diversity of the MHC class I homolog MIC-B, a stress-inducible ligand for the activating immunoreceptor NKG2D.
- Herpes simplex virus type 2-specific CD8 cytotoxic T lymphocyte cross-reactivity against prevalent HLA class I alleles.
- Oligonucleotide arrays for high-throughput SNPs detection in the MHC class I genes: HLA-B as a model system.
- HLA matching and hematopoietic cell transplant outcome.
- Genetic variation in TLR or NFkappaB pathways and the risk of Breast cancer: a case-control study.
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Anemia
- Breast Cancer
- Chronic Myeloid Leukemia (CML)
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Education
-
University of Washington -
McGill University Faculty of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. David White, MD |
|
|
Dr. Mary L. Disis, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Sherrill J. Slichter, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Keith D. Eaton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Henry Li, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David E. Dong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zhao Ming Dong, MD |
|
|
Dr. Kristine C. Doney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul J. Martin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Day F. Hills, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachel B. Salit, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maxwell M. Krem, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sam H. Whiting, MD |
|
|
Dr. Charles M. Bagley Jr., MD |
|
|
Dr. Daniel N. Egan, MD |
|
|
Dr. Claudia C. Astigarraga, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William E. Hobbs II, MD |
|
|
Dr. Emily A. Stevens, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Ibraheem M. Othman |